Syncolostemon parviflorus
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Syncolostemon parviflorus |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Syncolostemon Parviflorus |
| Ipni Id | 460169-1 |
| Plant Name | Syncolostemon Parviflorus |
| Genus Tax Id | 204204 |
| Disease Name | Head and neck cancer, Multiple myeloma, Solid tumour/cancer, Stomach cancer, Type-1/2 diabete, Vaginitis, Psoriasis, Mature B-cell leukaemia, Autonomic nervous system disorder, Sepsis, Metastatic lymph node neoplasm, Breast cancer, Malignant digestive organ neoplasm, Cardiovascular disease, Unspecific body region injury, Chemoprotection, Psychotic disorder, Malignant haematopoietic neoplasm, Vasomotor/allergic rhinitis, BCR-ABL1-negative chronic myeloid leukaemia, Extraocular muscle disorder, Acute myeloid leukaemia, Postoperative inflammation, Pain, unspecified, Bacterial infection, Thyroid cancer, Pleomorphic sarcoma, Pancreatic cancer, Lung cancer, Myeloproliferative neoplasm, Type 2 diabetes mellitus, Dementia, Parkinsonism, Herpes simplex infection, Biliary tract cancer, Brain cancer, Thrombosis, Diabetes mellitus, type unspecified, Colorectal cancer, Coronary thrombosis, Ischemia, Gout, Atopic eczema, Menstrual cycle bleeding disorder, Nutritional deficiency, Myocardial infarction, Cushing syndrome, Esophageal cancer, Christmas disease, Mature T-cell lymphoma, Crohn disease, Endometriosis, Synthesis disorder, Chronic kidney disease, Mature B-cell lymphoma, Acute diabete complication, Metastatic malignant neoplasm, Skin postprocedural disorder, Carcinoid syndrome, Urinary tract infection, Intracerebral haemorrhage, Metastatic biliary tract neoplasms, Alzheimer disease, Digestive organ benign neoplasm, Prostate cancer, Ovarian cancer, Rheumatoid arthritis, Chronic myelomonocytic leukaemia, Retinopathy, Otitis externa, Substance abuse, Metabolic disorder, Chronic arterial occlusive disease, Ocular cancer, Non-small cell lung cancer, Coronavirus infection, Fragile X chromosome, Bladder cancer, Kaposi sarcoma, Irritable bowel syndrome, Motor neuron disease, Chronic pain, Skin and skin-structure infection, Hyper-lipoproteinaemia, Inborn purine/pyrimidine/nucleotide metabolism error, Liver cancer, Ischemic heart disease, Myelodysplastic syndrome, Multiple sclerosis, Pediculosis, Female genital tract noninflammatory disorder, Peritoneal cancer, Acquired prion disease, Cerebral ischaemia, Glaucoma, Synovial sarcoma, Bleeding disorder, Lip/oral cavity/pharynx neoplasm, Otitis media, Melanoma, Indeterminate colitis, Prostate hyperplasia, Acute respiratory distress syndrome, Thrombocytopenia, Pituitary gland disorder, Follicular lymphoma, Asthma, Renal cell carcinoma, Transplanted organ/tissue, Phakomatoses/hamartoneoplastic syndrome, Osteosarcoma, Anogenital warts, Epidermal dysplasias, Peroxisomal disease, Ischaemic/haemorrhagic stroke, Mastocytosis, Nasopharyngeal cancer, Menopausal disorder, Seborrhoeic dermatitis, Parasitic worm infestation, Malignant mesenchymal neoplasm, Oesophagitis, Venous thromboembolism, Angina pectoris, Cervical cancer, Non-alcoholic fatty liver disease, Bone/articular cartilage neoplasm, HIV-infected patients with tuberculosis, Transplant rejection, Testicular cancer, Idiopathic interstitial pneumonitis, Filariasis, Supraventricular tachyarrhythmia, Male infertility, Leiomyosarcoma, Fallopian tube cancer, Thyrotoxicosis, Unspecific substance harmful effect, Lupus erythematosus, Acne vulgaris, Coagulation defect, Liver disease, Metastatic digestive system neoplasm, Syphilis, Adrenal cancer, Breast in situ carcinoma, Unspecified viral infection of unspecified site, Multiple structural anomalies syndrome, Fungal infection, Blood-forming organ disease, Metastatic tumour, Deep vein thrombosis, Myotonic disorder, Common warts, Adrenomedullary hyperfunction, Myasthenia gravis, Low bone mass disorder, Metastatic liver/bile duct neoplasm, Gonococcal infection, Influenza, Female infertility, Neuropathy, Acute/subacute hepatic failure, Obesity, Inborn lipid metabolism error, Dyslipidemia, Endometrial cancer, Choreiform disorder, Ovarian dysfunction, Colon cancer, Attention deficit hyperactivity disorder, Diffuse large B-cell lymphoma, Schizophrenia, Autoimmune disease, Gastrointestinal stromal tumour, Hypopharyngeal cancer, Inflammatory arthropathy, Hyperlipidemia, Ophthalmic devices/implants/grafts injury, Urethral cancer, Encephalopathy, Human immunodeficiency virus disease, Autism spectrum disorder, Dyspareunia, Spinal cord/cranial nerve neoplasm, Liposarcoma, Diabetic foot ulcer, Hepatitis virus infection, Cataract, Mild neurocognitive disorder, Muscular dystrophy, Oesophageal/gastroduodenal disorder, Skeletal anomaly, Cerebral ischaemic stroke, Mineral deficiency, Kidney failure, Respiratory system disease, Pulmonary hypertension, Lysosomal disease, Heart failure, Female pelvic pain, Ageing associated decline in intrinsic capacity, Malignant neoplasms of other or unspecified parts of mouth, Osteoarthritis, Chronic myeloid leukaemia, NOS, Central nervous system disease, Tension-type headache, coronary artery disease, Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source, Bronchiectasis, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Malignant neoplasms of kidney, except renal pelvis, COVID-19, Cystic fibrosis, Hearing disorder, Bacterial meningitis, Constipation, Septic shock, Diseases of the visual system, unspecified, Premenstrual tension syndrome, Chronic obstructive pulmonary disease, Intracranial injury, unspecified, Congenital aplastic anaemia, Other specified increased intracranial pressure, Pulpitis, Nephrocalcinosis, Cerebral oedema, Oligodendroglioma, anaplastic, Primary sclerosing cholangitis, Unspecified malignant neoplasms of unspecified sites, Acute pancreatitis, Wheezing, Allergic/hypersensitivity disorder, Lichen planus, Dysplastic naevus, Glioma, malignant, Glioblastoma, primary, NOS, Chronic hepatitis C, Postherpetic polyneuropathy, Malaria, Adenocarcinoma of prostate, Gastro-oesophageal reflux disease, Allergic conjunctivitis, Diabetic polyneuropathy, Macular degeneration, Hypotension, Kidney failure, unspecified, Structural developmental anomaly of heart or great vessels, unspecified, Maternal care for signs of fetal hypoxia, Obstructive sleep apnoea, Single episode depressive disorder, severe, without psychotic symptoms, Opioid use disorder, Cholelithiasis, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Zika virus disease, Osteoarthritis, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Idiopathic pulmonary fibrosis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Malignant neoplasms of bladder, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic sclerosis, Chronic rhinosinusitis, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Polycystic ovary syndrome, Dilated cardiomyopathy, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Ebola virus disease, Malignant neoplasms of adrenal gland, Malignant neoplasm of pancreas, Lyme borreliosis, Gliomas of brain |
| Species Name | Syncolostemon parviflorus |
| Genus Name | Syncolostemon |
| Species Tax Id | 231075 |
| Disease Id | 2D42, 2A83, 2A00-2F9Z, 2B72, 5A10-5A11, GA02, EA90, 2A82, 8D87, 1G40-1G41, 2D60, 2C60-2C6Y, 2C11, BA00-BE2Z, ND56, N.A., 6A20-6A25, 2B33, CA08, 2A41, 9C82, 2A60, 1A00-CA43, MG3Z, 1A00-1C4Z, 2D10, 2B54, 2C10, 2C25, 2A20, 5A11, 6D80-6D8Z, 8A00, 1F00, 2C17, 2A00, DB61-GB90, 5A14, 2B91, BA43, 8B10-8B11, FA25, EA80, GA20, 5B50-5B71, BA41-BA43, 5A70, 2B70, 3B11, 2A90, DD70, GA10, 5C52-5C59, GB61, 2A85, 5A2Y, 2D50-2E09, EL8Y, 5B10, GC08, 8B00, 2C14-2C17, 8A20, 2.00E+92, 2C82, 2C73, FA20, 2A40, 9B71, AA00-AA13, 6C40, 5C50-5D2Z, BD4Z, 2D00-2D07, 1D92, LD55, 2C94, 2B57, DD91, 8B60, MG30, 1F28-1G0Z, 5C80, 5C55, 2C12, BA40-BA6Z, 2A37, 8A40, 1G00, GA1Y, 2C51, 8.00E+01, 8B1Z, 9C61, 2B5A, GA20-GA21, 2B6E, AA80-AB0Z, 2C30, DD72, GA90, CB00, 3B64, 5A60-5A61, 2A80, CA23, 2C90, QB63, LD2D, 2B51, 1A95, EK90, 5C57, 8B20, 2A21, 2B6B, GA30, EA81, 1F90, 2B5D-2B5Y, DA24, BD72, BA40, 2C77, DB92, 2F7B, 1B10-1B14, NE84, 2C80, CB03, 1F66, BC81, GB04, 2B58, 2C74, 5A02, NE6Z, 4A40, ED80, 3B10, DB90-DB9Z, 2D8Y, 1A61-1A6Z, 2D11, 2.00E+65, 1D9Z, LD2F, 1F29-1F2F, 3C0Z, 2D50-2E2Z, BD71, 8C71, 1.00E+80, 5A75, 8C6Y, FB83, 2D80, 1A70-1A7Z, 1E30-1E32, GA31, 8C0Z, DB91, 5B80-5B81, 5C52, 5C80-5C81, 2C76, 8A01, 5A80, 2B90, 6A05, 2A81, 6A20, 4A40-4A45, 2B5B, 2B6D, FA2Z, PK97, 2C93, 8.00E+47, 1C60-1C62, 6A02, GA12, 2A02, 2B59, BD54, 1E50-1E51, 9B10, 6D71, 8C70, DD90, LD24, 8B11, 5B5K, GB60-GB6Z, CB40-CB7Z, BB01, 5C56, BD10-BD1Z, GA34, MG2A, 2B66, FA00-FA05, XH4XG8, 8A04-8D87, 8A81, BA8Y-BA8Z, PH56, CA24, 1C62.Z, 1D6Y, CA25, AB50-AB57, 1D01.0, ME05.0, XS26, 9E1Z, GA34.40, CA22, NA07.Z, 3A70.0, 8D60.Y, DA09.0, GB57, 8D60.1, XH8844, DB96.2, 2D4Z, DC31, MD11.C, 4A80-4A8Z, EA91, XH9035, XH4RQ3, XH0MB1, 1E51.1, 1E91.5, 1F40-1F45, 2C82.0, DA22, 9A60.02, 8C03.0, 9B75, BA20-BA21, GB6Z, LA8Z, JA86.2, 7A41, 6A70.3, 6C43, DC11, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, 1D48, FA0Z, 1D2Z, 2C15, 2C12.01, 1F54, CB03.4, 2B72.0, BC81.3, 2D60.0, 8C71.0, 2C90.Y, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, 4A42, CA0A, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 5A80.1, BC43.0, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 8C10.0, 1D60.01, 1C1G, 2A00.0 |
| Family Name | Lamiaceae |
| Family Tax Id | 4136 |
- 1. (10r,11r)-10-[(14r,15s,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaene-8,14,26,31-Tetrone (PubChem CID: 44584736)
- 2. (10r,11r)-10-[(14r,15s,19s)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaene-8,14,26,31-Tetrone (PubChem CID: 153274273)
- 3. (10r,11r)-10-[(14s,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaene-8,14,26,31-Tetrone (PubChem CID: 44567110)
- 4. (10r,11r)-10-[(14s,15s,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,11,16,17,18,21,22,33,34-Undecahydroxy-9,24,31-Trioxaheptacyclo[24.8.0.02,7.014,19.020,29.023,28.027,32]tetratriaconta-1(34),2,4,6,14,16,18,20,22,26,28,32-Dodecaene-8,13,25,30-Tetrone (PubChem CID: 162883503)
- 5. (10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-Octahydroxy-13-(Hydroxymethyl)-9,12,16-Trioxatetracyclo[16.4.0.02,7.010,15]docosa-1(22),2,4,6,18,20-Hexaene-8,17-Dione (PubChem CID: 11754973)
- 6. (10s,11r,12s,13r,15s)-3,4,5,11,12,13,21,22,23,26,27,38,39-Tridecahydroxy-9,14,17,29,36-Pentaoxaoctacyclo[29.8.0.02,7.010,15.019,24.025,34.028,33.032,37]nonatriaconta-1(39),2,4,6,19,21,23,25,27,31,33,37-Dodecaene-8,18,30,35-Tetrone (PubChem CID: 162917712)
- 7. (10s,11s,13s,47r,48s)-3,4,5,11,19,20,21,24,25,36,37,40,41,42,52,53,54-Heptadecahydroxy-9,12,15,27,34,46,49-Heptaoxaundecacyclo[49.3.1.02,7.010,48.013,47.017,22.023,32.026,31.029,38.030,35.039,44]pentapentaconta-1(55),2,4,6,17,19,21,23,25,29,31,35,37,39,41,43,51,53-Octadecaene-8,16,28,33,45,50-Hexone (PubChem CID: 163040145)
- 8. (1r,2s,4as,6ar,6as,6bs,8as,10s,12ar,14br)-10-Hydroxy-1,2,6a,6b,9,9,12a-Heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-Tetradecahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 162948465)
- 9. (1r,2s,8r,10r,19r,20s,39s)-8,9,9,13,14,25,26,27,30,31,32,39-Dodecahydroxy-3,18,21,36,38,40-Hexaoxaoctacyclo[18.17.1.12,19.18,12.05,10.011,16.023,28.029,34]tetraconta-5,11,13,15,23,25,27,29,31,33-Decaene-4,7,17,22,35-Pentone (PubChem CID: 163060266)
- 10. (1r,35r,37r,38r,55s)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-Heptadecahydroxy-2,14,21,33,36,39,54-Heptaoxaundecacyclo[33.20.0.04,9.010,19.013,18.016,25.017,22.026,31.038,55.041,46.047,52]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,41,43,45,47,49,51-Octadecaene-3,15,20,32,40,53-Hexone (PubChem CID: 16148440)
- 11. (1r,35r,37r,38s,39s)-6,7,8,11,12,23,24,27,28,29,37,38,39-Tridecahydroxy-2,14,21,33,36-Pentaoxaoctacyclo[33.2.2.04,9.010,19.013,18.016,25.017,22.026,31]nonatriaconta-4,6,8,10,12,16,18,22,24,26,28,30-Dodecaene-3,15,20,32-Tetrone (PubChem CID: 162852731)
- 12. (1r,35s,37r,38r,55s)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-Heptadecahydroxy-2,14,21,33,36,39,54-Heptaoxaundecacyclo[33.20.0.04,9.010,19.013,18.016,25.017,22.026,31.038,55.041,46.047,52]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,41,43,45,47,49,51-Octadecaene-3,15,20,32,40,53-Hexone (PubChem CID: 163000163)
- 13. (1s,2r,4as,6ar,6as,6br,8as,9r,10r,11r,12ar,14bs)-10,11-Dihydroxy-9-(Hydroxymethyl)-1,2,6a,6b,9,12a-Hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-Tetradecahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 51531959)
- 14. (1s,35r,36s,53r,54s)-6,7,8,11,12,23,24,27,28,29,41,42,43,46,47,48,54-Heptadecahydroxy-2,14,21,33,37,52,55-Heptaoxaundecacyclo[33.18.2.04,9.010,19.013,18.016,25.017,22.026,31.036,53.039,44.045,50]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,39,41,43,45,47,49-Octadecaene-3,15,20,32,38,51-Hexone (PubChem CID: 162934030)
- 15. (1s,37r,39s,40r,57r)-7,8,9,12,13,24,25,28,29,30,39,45,46,47,50,51,52-Heptadecahydroxy-2,3,15,22,34,35,38,41,56-Nonaoxaundecacyclo[35.20.0.05,10.011,20.014,19.017,26.018,23.027,32.040,57.043,48.049,54]heptapentaconta-5,7,9,11,13,17,19,23,25,27,29,31,43,45,47,49,51,53-Octadecaene-4,16,21,33,42,55-Hexone (PubChem CID: 162935026)
- 16. (26r,27s,44r,45s,47r)-3,4,15,16,19,20,21,32,33,34,37,38,39,45,52,53,54-Heptadecahydroxy-6,13,25,28,43,46,49-Heptaoxaundecacyclo[49.3.1.02,11.05,10.08,17.09,14.018,23.026,47.027,44.030,35.036,41]pentapentaconta-1(55),2,4,8,10,14,16,18,20,22,30,32,34,36,38,40,51,53-Octadecaene-7,12,24,29,42,50-Hexone (PubChem CID: 163005441)
- 17. (2r,3s)-3-[(10r,11s)-3,4,5,11,16,17,18-Heptahydroxy-8,14-Dioxo-9,13-Dioxatricyclo[13.3.1.02,7]nonadeca-1(19),2,4,6,15,17-Hexaen-10-Yl]-2,3-Bis[(3,4,5-Trihydroxybenzoyl)oxy]propanoic Acid (PubChem CID: 162963168)
- 18. (2r,3s,4s,5r,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-(2-Phenylethoxy)oxane-3,4,5-Triol (PubChem CID: 13893575)
- 19. (2r,3s,4s,5r,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-[(E)-3-(4-Hydroxy-3,5-Dimethoxyphenyl)prop-2-Enoxy]oxane-3,4,5-Triol (PubChem CID: 11386564)
- 20. (2s)-2,5,7-Trihydroxy-2-(4-Hydroxyphenyl)-4h-Chromen-3-One (PubChem CID: 162849938)
- 21. (2s)-2-(2,5-Dihydroxy-4-Methoxyphenyl)-5,6,8-Trihydroxy-7-[(2s,3r,4s,5r)-3,4,5-Trihydroxyoxan-2-Yl]oxy-2,3-Dihydrochromen-4-One (PubChem CID: 162895369)
- 22. (2s)-5,6,7,8-Tetrahydroxy-2-(2,3,5-Trihydroxy-4-Methoxyphenyl)-2,3-Dihydrochromen-4-One (PubChem CID: 162926145)
- 23. (2s)-7-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5s)-3,4-Dihydroxy-5-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-3,4,5-Trihydroxyoxan-2-Yl]oxy-2-(3,4-Dihydroxyphenyl)-5-Hydroxy-2,3-Dihydrochromen-4-One (PubChem CID: 163016799)
- 24. (2s)-7-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5s)-3,4-Dihydroxy-5-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-3,4,5-Trihydroxyoxan-2-Yl]oxy-5-Hydroxy-2-(4-Methoxyphenyl)-2,3-Dihydrochromen-4-One (PubChem CID: 162845747)
- 25. (2s,3s,4s,5s,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-[(E)-3-(4-Hydroxy-3,5-Dimethoxyphenyl)prop-2-Enoxy]oxane-3,4,5-Triol (PubChem CID: 162923232)
- 26. (2s,3s,4s,5s,6r)-2-[[(2r,3r,4r)-3,4-Dihydroxy-4-(Hydroxymethyl)oxolan-2-Yl]oxymethyl]-6-[(E)-3-(4-Hydroxy-3-Methoxyphenyl)prop-2-Enoxy]oxane-3,4,5-Triol (PubChem CID: 162981462)
- 27. (3r,3ar,4r,6r,6as)-3,6-Bis(1,3-Benzodioxol-5-Yl)-1,3,3a,4,6,6a-Hexahydrofuro[3,4-C]furan-4-Ol (PubChem CID: 162932626)
- 28. (3r,8r,9r,10s,13r,14r,17s)-17-[(2r,5r)-5-Ethyl-6-Methylheptan-2-Yl]-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 162965363)
- 29. (4as,6as,6as,6br,8ar,12as,14bs)-12a-(Hydroxymethyl)-2,2,6a,6b,9,9-Hexamethyl-10-Oxo-3,4,5,6,6a,7,8,8a,13,14b-Decahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 163075661)
- 30. (4as,6as,6as,6br,8ar,12r,12ar,14bs)-12-Hydroxy-2,2,6a,6b,9,9,12a-Heptamethyl-10-Oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-Dodecahydro-1h-Picene-4a-Carboxylic Acid (PubChem CID: 15765604)
- 31. (8s,9s,13s,14r)-3-Hydroxy-13-Methyl-7,8,9,11,12,14,15,16-Octahydro-6h-Cyclopenta[A]phenanthren-17-One (PubChem CID: 670995)
- 32. (E,1s,8r,10s,11s)-4,8-Dimethyl-1-[(1r,2s)-2,6,6-Trimethylcyclohex-3-En-1-Yl]tridec-3-Ene-1,8,10,11-Tetrol (PubChem CID: 162948211)
- 33. 1,2,3-Tri-O-Galloyl-Beta-D-Glucose (PubChem CID: 5322038)
- 34. 1,2,4,6-Tetra-O-Galloyl-Beta-D-Glucose (PubChem CID: 11297287)
- 35. 1,2,4-Tri-O-Galloyl-Beta-Glucopyranose (PubChem CID: 88204715)
- 36. 1,2,6-Trigalloylglucose (PubChem CID: 440308)
- 37. 1,3,4-Tri-O-Galloyl-Beta-Glucopyranose (PubChem CID: 16066749)
- 38. 1,4,6-Tri-O-Galloyl-Beta-D-Glucose (PubChem CID: 10077822)
- 39. 1-[(2r)-Piperidin-2-Yl]propan-2-One (PubChem CID: 3034881)
- 40. 1-[(2s)-1-Methylpiperidin-2-Yl]propan-2-One (PubChem CID: 820378)
- 41. 1-Desgalloyleugeniin (PubChem CID: 9918701)
- 42. 13-Hydroxy-12-Methoxy-3,5,10,17-Tetraoxapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2(6),7,11(19),12,14-Hexaene-9,16-Dione (PubChem CID: 10336592)
- 43. 2,3,8-Tri-O-Methylellagic Acid (PubChem CID: 5281860)
- 44. 2-[3-[[(1r,5s)-6,6-Dimethyl-2-Bicyclo[3.1.1]hept-2-Enyl]methyl]-4-Hydroxyphenyl]-3,7,8-Trihydroxychromen-4-One (PubChem CID: 162983852)
- 45. 24-Hydroxyursolic Acid (PubChem CID: 44568920)
- 46. 3,3'-Di-O-Methylellagic Acid (PubChem CID: 5488919)
- 47. 3,3a(2),4a(2)-Tri-O-Methylellagic Acid (PubChem CID: 11674590)
- 48. 3-(Hydroxymethylidene)pyran-4-One (PubChem CID: 101406579)
- 49. 3-O-Methylellagic Acid (PubChem CID: 13915428)
- 50. 3-O-Methylellagic Acid 4-O-Rhamnoside (PubChem CID: 16720461)
- 51. 5,7-Dihydroxy-2-[4-Hydroxy-3-[(2s,3r,4s,5r)-3,4,5-Trihydroxyoxan-2-Yl]oxyphenyl]chromen-4-One (PubChem CID: 101675298)
- 52. 5-Desgalloylstachyurin (PubChem CID: 10417809)
- 53. 6-[(E)-Prop-1-Enyl]-2,3,4,5-Tetrahydropyridine (PubChem CID: 15937508)
- 54. 6-[[(2r,3s,4s,5r,6s)-6-[(2s,3r,4s,5r,6s)-4,5-Dihydroxy-2-Methyl-6-[(7,13,14-Trihydroxy-3,10-Dioxo-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaen-6-Yl)oxy]oxan-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methoxy]-7,13,14-Trihydroxy-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaene-3,10-Dione (PubChem CID: 11968423)
- 55. 6-[[(2r,3s,4s,5r,6s)-6-[(2s,3r,4s,5s,6r)-4,5-Dihydroxy-2-Methyl-6-[(7,13,14-Trihydroxy-3,10-Dioxo-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaen-6-Yl)oxy]oxan-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methoxy]-7,13,14-Trihydroxy-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaene-3,10-Dione (PubChem CID: 163005628)
- 56. 6-Prop-1-Enyl-2,3,4,5-Tetrahydropyridine (PubChem CID: 76453742)
- 57. 7,8,9-Trihydroxy-1,2-Dihydrocyclopenta[C]isochromene-3,5-Dione (PubChem CID: 10131135)
- 58. 7-Hydroxy-6,14-Dimethoxy-13-[(2s,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxy-2,9-Dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-Hexaene-3,10-Dione (PubChem CID: 162978332)
- 59. 8-O-[(1r,19r,21r,22r,23r)-6,7,8,11,12,13,22-Heptahydroxy-3,16-Dioxo-21-(3,4,5-Trihydroxybenzoyl)oxy-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-Hexaen-23-Yl] 1-O-Methyl (1r,3ar,8br)-5,6-Dihydroxy-3a-(2-Methoxy-2-Oxoethyl)-3-Oxo-1,8b-Dihydrofuro[3,4-B][1]benzofuran-1,8-Dicarboxylate (PubChem CID: 71475292)
- 60. 8-O-[(1r,19r,21r,22r,23r)-6,7,8,11,12,13,22-Heptahydroxy-3,16-Dioxo-21-(3,4,5-Trihydroxybenzoyl)oxy-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-Hexaen-23-Yl] 1-O-Methyl (1s,3ar,8br)-5,6-Dihydroxy-3a-(2-Methoxy-2-Oxoethyl)-3-Oxo-1,8b-Dihydrofuro[3,4-B][1]benzofuran-1,8-Dicarboxylate (PubChem CID: 163009667)
- 61. [(10r,11r)-10-[(14r,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,16,17,18,21,22,33,34-Decahydroxy-8,13,25,30-Tetraoxo-9,24,31-Trioxaheptacyclo[24.8.0.02,7.014,19.020,29.023,28.027,32]tetratriaconta-1(34),2,4,6,14,16,18,20,22,26,28,32-Dodecaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163006263)
- 62. [(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-Octahydroxy-8,17-Dioxo-9,12,16-Trioxatetracyclo[16.4.0.02,7.010,15]docosa-1(22),2,4,6,18,20-Hexaen-13-Yl]methyl 3,4,5-Trihydroxybenzoate (PubChem CID: 14428069)
- 63. [(10r,11s)-10-[(14r,15s,19s)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-3,4,5,17,18,19-Hexahydroxy-8,14-Dioxo-9,13-Dioxatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-Hexaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 17999934)
- 64. [(10r,11s)-3,4,5,17,18,19,22,23,34,35-Decahydroxy-10,11-Dimethyl-8,14,26,31-Tetraoxo-10-[(1s)-1-[(3r,4r)-4,5,6,7-Tetrahydroxy-3-Methyl-1-Oxo-4h-Isochromen-3-Yl]-1-(3,4,5-Trihydroxybenzoyl)oxyethyl]-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162851938)
- 65. [(10r,11s,12r,13s,15s)-3,4,5,11,21,22,23-Heptahydroxy-8,18-Dioxo-13-(3,4,5-Trihydroxybenzoyl)oxy-9,14,17-Trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,19,21-Hexaen-12-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162959404)
- 66. [(10s,11s,12r,13s,15r)-3,4,5,11,13,21,22,23,26,27,38,39-Dodecahydroxy-8,18,30,35-Tetraoxo-9,14,17,29,36-Pentaoxaoctacyclo[29.8.0.02,7.010,15.019,24.025,34.028,33.032,37]nonatriaconta-1(39),2,4,6,19,21,23,25,27,31,33,37-Dodecaen-12-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163048086)
- 67. [(10s,11s,12s,13r,15r)-3,4,5,12,21,22,23-Heptahydroxy-8,18-Dioxo-13-(3,4,5-Trihydroxybenzoyl)oxy-9,14,17-Trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,19,21-Hexaen-11-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163086347)
- 68. [(1r,19r,21s,22r,23r)-6,7,8,11,12,13,22-Heptahydroxy-3,16-Dioxo-21-(3,4,5-Trihydroxybenzoyl)oxy-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-Hexaen-23-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 14411426)
- 69. [(1r,2s)-1-[(14r,15s,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-1,3-Dihydroxypropan-2-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162994710)
- 70. [(1r,2s)-1-[(14s,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-1,3-Dihydroxypropan-2-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162994708)
- 71. [(1s,19r,21s,22r,23r)-5,6,7,8,11,12,13,14,22,23-Decahydroxy-3,16-Dioxo-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4(9),5,7,10(15),11,13-Hexaen-21-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163190909)
- 72. [(1s,19r,21s,22r,23r)-5,6,7,8,11,12,13,14-Octahydroxy-3,16-Dioxo-21,22-Bis[(3,4,5-Trihydroxybenzoyl)oxy]-2,17,20-Trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4(9),5,7,10(15),11,13-Hexaen-23-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162857441)
- 73. [(1s,2s)-1-[(14s,15r,19r)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-1,3-Dihydroxypropan-2-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162994709)
- 74. [(2r)-2,3-Bis[[(9z,11e,13z)-Octadeca-9,11,13-Trienoyl]oxy]propyl] (9z,12z,14e)-Nonadeca-9,12,14-Trienoate (PubChem CID: 163025003)
- 75. [(2r)-2,3-Dihydroxypropyl] (9e,11z,13e)-Octadeca-9,11,13-Trienoate (PubChem CID: 163082131)
- 76. [(2r)-2-Hydroxy-3-(3-Methylbutoxy)propyl] Octadec-2-Enoate (PubChem CID: 163029346)
- 77. [(2r,3r)-3-[(14s,15r,19s)-2,3,4,7,8,9,19-Heptahydroxy-12,17-Dioxo-13,16-Dioxatetracyclo[13.3.1.05,18.06,11]nonadeca-1,3,5(18),6,8,10-Hexaen-14-Yl]-2,3-Dihydroxypropyl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163044145)
- 78. [(2r,3s,4s,5r,6s)-3,4,5,6-Tetrahydroxyoxan-2-Yl]methyl 3,4,5-Trihydroxybenzoate (PubChem CID: 11968480)
- 79. [(4r)-4-Hydroxynon-6-Enyl] Benzoate (PubChem CID: 162870803)
- 80. Alpha-Pedunculagin (PubChem CID: 13834142)
- 81. Apigenin-4'-Glucoside (PubChem CID: 5491384)
- 82. Beta-Phenylethanol Beta-D-Rutinoside (PubChem CID: 11166301)
- 83. Beta-Sitosterol (PubChem CID: 222284)
- 84. Beta-Sitosteryl Acetate (PubChem CID: 5354503)
- 85. Betulin (PubChem CID: 72326)
- 86. Betulinic Acid (PubChem CID: 64971)
- 87. Borneol (PubChem CID: 6552009)
- 88. Cid 3003153 (PubChem CID: 3003153)
- 89. Cid 5464368 (PubChem CID: 5464368)
- 90. Corilagin (PubChem CID: 73568)
- 91. Cyanidin (PubChem CID: 128861)
- 92. Delphinidin 3,5-Diglucoside (PubChem CID: 10100906)
- 93. Ellagic Acid (PubChem CID: 5281855)
- 94. Epifriedelin (PubChem CID: 15559350)
- 95. Eschweilenol C (PubChem CID: 10026656)
- 96. Estrone (PubChem CID: 5870)
- 97. Ethyl (1r)-7,8,9-Trihydroxy-3,5-Dioxo-1,2-Dihydrocyclopenta[C]isochromene-1-Carboxylate (PubChem CID: 162850267)
- 98. Ethyl (6r)-4-(2-Ethoxy-2-Oxoethyl)-11,12-Dihydroxy-3,8-Dioxo-2,7-Dioxatricyclo[7.3.1.05,13]trideca-1(13),4,9,11-Tetraene-6-Carboxylate (PubChem CID: 162942104)
- 99. Flavogallonic Acid (PubChem CID: 14503023)
- 100. Flavylium, 3,3',4',5,5',7-Hexahydroxy- (PubChem CID: 128853)
- 101. Friedelin (PubChem CID: 91472)
- 102. Galactitol (PubChem CID: 11850)
- 103. Gallagic Acid (PubChem CID: 14754405)
- 104. Gallic Acid (PubChem CID: 370)
- 105. Galloyl(-4)glc(B1-6)glc(B)-O-Galloyl (PubChem CID: 162844808)
- 106. Glc(B1-4)glc(B1-4)glc(B1-4)glc6me(B1-4)a-Rha (PubChem CID: 162975384)
- 107. Glycerin (PubChem CID: 753)
- 108. Granatan-3-One (PubChem CID: 6602484)
- 109. I(2)-D-Glucopyranoside, (2e)-3-(4-Hydroxy-3-Methoxyphenyl)-2-Propenyl 6-O-D-Apio-I(2)-D-Furanosyl (PubChem CID: 11408873)
- 110. Lupeol (PubChem CID: 259846)
- 111. Luteolin (PubChem CID: 5280445)
- 112. Luteolin-4'-O-Glucoside (PubChem CID: 5319116)
- 113. Mannitol (PubChem CID: 6251)
- 114. Maslinic Acid (PubChem CID: 73659)
- 115. Methyl (1s,2s,6s,7s,8r,11s,14s,15r,18r,20s)-20-Hydroxy-7,8,14,15,19,19-Hexamethyl-21-Oxahexacyclo[18.2.2.01,18.02,15.05,14.06,11]tetracos-4-Ene-11-Carboxylate (PubChem CID: 163010693)
- 116. Methyl Gallate (PubChem CID: 7428)
- 117. Myricetin (PubChem CID: 5281672)
- 118. N-Methylpelletierine (PubChem CID: 1548928)
- 119. Oleanolic Acid (PubChem CID: 10494)
- 120. Oleic Acid (PubChem CID: 445639)
- 121. Pelargonin (PubChem CID: 441772)
- 122. Pentagalloylglucose (PubChem CID: 65238)
- 123. Pregnenolone (PubChem CID: 8955)
- 124. Punicafolin (PubChem CID: 5320800)
- 125. Punicanolic Acid (PubChem CID: 25132490)
- 126. Punicic Acid (PubChem CID: 5281126)
- 127. Punigluconin (PubChem CID: 21637585)
- 128. Quercetin (PubChem CID: 5280343)
- 129. Sakuranin (PubChem CID: 73607)
- 130. Sesamin, (-)- (PubChem CID: 382073)
- 131. Sitogluside (PubChem CID: 5742590)
- 132. Stigmasterol (PubChem CID: 5280794)
- 133. Stigmasterol Glucoside (PubChem CID: 6602508)
- 134. Strictinin (PubChem CID: 73330)
- 135. Tricetin (PubChem CID: 5281701)
- 136. Ursolic Acid (PubChem CID: 64945)
- 137. Verbascoside (PubChem CID: 5281800)
- 1. Alzheimer's Disease 1
- 2. Arthritis
- 3. Arthritis, Gouty
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Brain Edema
- 7. Bronchiectasis
- 8. Cardiovascular Diseases
- 9. Cataract
- 10. Celiac Disease
- 11. Chancre
- 12. Cholelithiasis
- 13. Cholera
- 14. Common Wart
- 15. Constipation
- 16. Coronary Artery Disease
- 17. Crohn Disease
- 18. Cystic Fibrosis
- 19. Dementia
- 20. Diabetes Mellitus
- 21. Diabetes Mellitus, Type 1
- 22. Esophagitis
- 23. Female Infertility Of Uterine Origin
- 24. Filariasis
- 25. Glaucoma
- 26. Gonorrhea
- 27. Hematologic Diseases
- 28. Infertility, Male
- 29. Inflammatory Bowel Diseases
- 30. Influenza, Human
- 31. Liver Neoplasms
- 32. Lupus Erythematosus, Systemic
- 33. Muscular Dystrophies
- 34. Myocardial Infarction
- 35. Neoplasms
- 36. Obesity
- 37. Osteoarthritis
- 38. Pre-Eclampsia
- 39. Psoriasis
- 40. Psychotic Disorder
- 41. Scleroderma, Systemic
- 42. Thrombocytopenia
- 43. Urinary Tract Infections
- 44. Vaginitis
Not listed in any formulations.